Brief: Karuna Therapeutics Reports First Quarter 2023 Financial Results And Provides General Business Updates
04/05/2023 11:37
Karuna Therapeutics Inc KRTX.O :
* KARUNA THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES GENERAL BUSINESS UPDATES
* KARUNA THERAPEUTICS INC- $1.5 BILLION IN CASH EXPECTED TO
FUND
OPERATIONS THROUGH 2026
* KARUNA THERAPEUTICS INC - QTRLY LOSS PER SHARE $2.80
Source text for Eikon: ID:nBw1Vh7tna
Further company coverage: KRTX.O
Recent news on Karuna Therapeutics
See all newsMoody's says pharma outlook turns 'positive' on GLP-1 drug push
Brief: Karuna Therapeutics Says Complaint Was Filed By Karuna Stockholder Seeking To Enjoin Proposed Merger With Bristol-Myers Squibb
Karuna Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Karuna Therapeutics Inc expected to post a loss of $2.65 a share - Earnings Preview
Bristol Myers posts better-than-expected 4th-quarter results (updated)